Indian Healthcare Segment: A Challenge to Human Security in 21st Century

Nandan Sharma

doi:10.53724/lrd/v2n1.06

Authors

Nandan Sharma Assistant Professor, School of Law, Shoolini University of Biotechnology and Management Sciences, Solan, HP Email Address: nandansharma5@gmail.com

DOI:

https://doi.org/10.53724/lrd/v2n1.06

Keywords:

Indian Healthcare Segment, A Challenge to Human Security in 21st Century, India Drugs and Cosmetics Act, 1940

Abstract

During the last three decades, the pharmaceutical sector has shown an explosive growth all over the world. After eatables, cosmetics and textile, pharmaceutical are rapidly surging ahead to become the third largest industry in several developed countries, thanks to health awareness propagated by World Health Organization (WHO).1 India has not lagged behind. Indian Pharmaceutical Industry in spite of tough competition, have got entrenched in eastern, mid-eastern and in several western markets. Some of our pharmaceutical multinationals have already acquired an edge over several well established foreign multinationals. Our pharmaceutical export revenue is increasing year after year. The researcher has highlighted the issue concerning the heath issues of the people of developing nations like India as a challenge for 21st century.

Metrics

Metrics Loading ...

References

Dr. (Brig.) M.L. Katria, “Drugs Aplenty, But not for common man,” Published in Oped Health, The Tribune, Dated 18th August 2014 p. 9.

Ibid

"WHO, WIPO, WTO join forces to put access to medicines under the microscope," A symposium held on 16 July, 2010, http://www.wto.org/english/news-e/news10-e/trip,21 June10-ehtm, (visited on 24/07/14)

WHO- Media Centre, “The top 10 causes of death,” http://who.int/media centre/fact sheets/fs 310/en, (Visited on 10/07/ 2013)

46th Annual Report 2011-12, Organization of Pharmaceutical Producers of India (OPPI), www. Indiaoppi.com/sites/2011-12_ 1 pdf, (Visited on 10 /10/ 2014)

Supriya Gupta, "Emerging Indian OTC Markets," Apeejay Journal of Management, Science and Technological, (Vol. 1),(2013), at p. 28

Ibid.

Drugs and cosmetic Rules framed in 1945 contains list of all prescribed and OTC drugs.

Supra note 17

www anthrajyothy.com (visited on 19/01/2015

Ibid

www.Indianmedicine.nic.in (Visited on 25/06/2016)

"Measuring medicine prices, availability and price components, 2nd Ed., World Health Organization, (2008), p. 1

Ibid

WHO Essential Medicines, www.who.in/topics/essential medicines/en (visited on 11 /03/ 2016)

Ibid

World Bank, “Indian- New Global Poverty Estimates,” http.// poverty data. World bank. org/ poverty/ country/ IND (Visited on 23 /05/ 2016)

Dr. Ajay Kumar, “Indian Patent Regime and its Impact on Life Saving Drugs,” Indian Bar Review (Vol. XXX), (2008),

p. 15 20 Ibid. 21 Ibid.

Rajnish Kumar Rai, “Battling with TRIPS: Emerging Firm Strategies of Indian Pharmaceutical Industries Post TRIPS,” Journal of Intellectual Property Rights, Vol. 13, July, (2008), p. 301

Ibid.

G.B. Reddy, “Impact of TRIPS Agreement on patent Regime in India with Special Reference to Health Care-strategies for the New Millennium, "Apex Court Expression, (2003), p.16.

Ibid.

See, Amarjit Singh Sethi, “Intellectual Property Rights and Pharmaceutical Sector in India", in Prankrishna Pal, Ed.

Intellectual Propety Right in India; General Issues and Implications, (2010), p. 145.

Ibid.

United Nations Development Report, UNDP, 2000, New Delhi, p. 84.

India Brand Equity Foundation, "India pharmaceutical Industry, http://www.ibef.org/industry/pharmaceutical-india.

Aspx, (Visited on 18 /01/2015)

Supra note 25 at 149

Mc Kinsey & company in a Report on, “Pharmaceutical and Medical Products and Pactice- India Pharma 2020 Propelling access and Acceptance